7 2 7 a r t I C l e S AMPA-selective glutamate receptors are ligand-gated cation channels that mediate fast excitatory neurotransmission in the brain and thus mediate many aspects of brain function including cognition, movement, learning and memory 1 . The function and number of postsynaptic AMPA receptors is dynamically regulated by phosphorylation to control synaptic strength, a key feature of cellular models of learning and memory 2 .
a r t I C l e S AMPA-selective glutamate receptors are ligand-gated cation channels that mediate fast excitatory neurotransmission in the brain and thus mediate many aspects of brain function including cognition, movement, learning and memory 1 . The function and number of postsynaptic AMPA receptors is dynamically regulated by phosphorylation to control synaptic strength, a key feature of cellular models of learning and memory 2 .
AMPA receptors are tetrameric assemblies of four subunits (GluA1-GluA4), each containing two semiautonomous extracellular domains, an amino-terminal domain and an agonist-binding domain. The agonist-binding domain is linked to three membrane-spanning α-helices and a pore-forming re-entrant loop 1, 3 . The crystal structure of a homomeric GluA2 receptor in an antagonist-bound state shows that the extracellular domain possesses approximate two-fold symmetry, while the ion channel pore-forming domains are arranged with four-fold symmetry 3 . Each subunit has an intracellular C-terminal segment downstream of the third membrane-spanning helix and contains phosphorylation sites that regulate receptor gating, trafficking and localization [4] [5] [6] [7] [8] .
Cellular models of synaptic plasticity, such as long-term potentiation (LTP), are characterized by an AMPA receptor-dependent increase in excitatory postsynaptic current amplitude at hippocampal CA1 pyramidal cells 9 . This results either from enhanced AMPA receptor function or increased delivery of AMPA receptors to the synapse 2, 6, 9, 10 , although the relative contribution of these mechanisms to LTP is not fully understood. In addition, both the AMPA receptor GluA1 subunit and CaMKII, a serine/threonine protein kinase highly expressed at excitatory synapses, are required for expression of LTP at mature hippocampal CA1 pyramidal cells [11] [12] [13] [14] [15] [16] . Biochemical studies have identified a CaMKII phosphorylation site at Ser831 on the C-terminal domain of the GluA1 subunit 5, 17, 18 . Whereas GluA1-Ser831 phosphorylation does not seem to increase synaptic localization of GluA1-containing receptors 19 , it does increase conductance of homomeric GluA1 receptors expressed in recombinant systems 4 . This potentiation is similar to the higher conductance of native AMPA receptors observed upon LTP 4, 10, [20] [21] [22] .
Here, we investigate the mechanism by which phosphorylation of native and recombinant GluA1-Ser831 increases AMPA receptor conductance. AMPA receptors exist in several open states with distinct conductances determined by agonist binding and the gating of individual subunits [23] [24] [25] [26] [27] . The AMPA receptor single-channel conductance is a function of the number of agonist-bound subunits per receptor complex that are activated at any given moment [23] [24] [25] [26] [27] . Our data support previous work showing that phosphorylation of GluA1-Ser831 does not change individual conductance amplitudes, but rather increases the relative occupation of larger conductance levels 4 . We show here that CaMKII increases conductance of both recombinant and native AMPA receptors by means of phosphorylation at GluA1-Ser831. A phosphomimic mutation in GluA1 enhances heteromeric GluA1-GluA2 receptor conductance when the TARPs stargazin or γ8 are present. Finally, phosphorylation of GluA1 at Ser831 can increase the efficiency by which each subunit translates ligand-induced conformational changes within the agonist binding domain to channel activation. We thus propose that CaMKII enhances
The function, trafficking and synaptic signaling of AMPA receptors are tightly regulated by phosphorylation. Ca 2+ /calmodulindependent kinase II (CaMKII) phosphorylates the GluA1 AMPA receptor subunit at Ser831 to increase single-channel conductance. We show that CaMKII increases the conductance of native heteromeric AMPA receptors in mouse hippocampal neurons through phosphorylation of Ser831. In addition, co-expression of transmembrane AMPA receptor regulatory proteins (TARPs) with recombinant receptors is required for phospho-Ser831 to increase conductance of heteromeric GluA1-GluA2 receptors. Finally, phosphorylation of Ser831 increases the efficiency with which each subunit can activate, independent of agonist efficacy, thereby increasing the likelihood that more receptor subunits will be simultaneously activated during gating. This underlies the observation that phospho-Ser831 increases the frequency of openings to larger conductances rather than altering unitary conductance. Together, these findings suggest that CaMKII phosphorylation of GluA1-Ser831 decreases the activation energy for an intrasubunit conformational change that regulates the conductance of the receptor when the channel pore opens. a r t I C l e S gating of individual subunits in GluA1-containing AMPA receptors to increase the single-channel conductance.
RESULTS

Control of neuronal AMPA receptor function by CaMKII
CaMKII phosphorylation of GluA1 enhances the single-channel conductance of recombinant homomeric receptors 4 . Previous work has identified residue Ser831 in the GluA1 subunit as the primary site for CaMKII phosphorylation 5, 13, 17, 18 (Fig. 1a) . We examined whether purified CaMKII affects the weighted mean conductance (γ MEAN ) of native hippocampal AMPA receptors, which express GluA1, GluA2 and GluA3 subunits 28 . Given the many AMPA receptor subunits expressed in hippocampal neurons, we assumed that AMPA receptors in outside-out patches had heterogeneous subunit compositions. We recorded macroscopic currents, induced by bath application of 1 mM glutamate to outside-out patches isolated from cultured hippocampal neurons (Fig. 1b) , either with or without purified CaMKII (2 U ml −1 ; see Online Methods) in the patch pipette (plus 0.1 µM Ca 2+ and 10 µg ml −1 calmodulin). dl-AP5 (dl-2-amino-5-phosphonovalerate, 100 µM) and Mg 2+ (1 mM) were added to the external solution to reduce the contribution of NMDA receptor activation, and cyclothiazide (100 µM) was added to reduce desensitization. A current response with a graded waveform ( Fig. 1a,b ) was generated by slowly washing glutamate from the bath. The γ MEAN of AMPA receptors in the patch can be estimated using variance analysis of the current response during washout of agonist 26, 29 (Fig. 1b,c) . Inclusion of purified CaMKII, Ca 2+ and calmodulin in the patch pipette significantly increased the γ MEAN from 4.3 ± 0.4 pS (n = 11; Fig. 1d ) to 9.3 ± 0.4 pS (n = 12; P < 0.001; Student's t-test; Fig. 1d ). These results show that CaMKII controls the conductance of native hippocampal AMPA receptors, consistent with previous observations on recombinant homomeric GluA1 receptors 4, 30 . The lower conductance observed in neurons compared to that in cells expressing homomeric GluA1 ( Fig. 1 and Table 1 ) suggests inclusion of edited GluA2 subunits, which lowers unitary conductance when assembled with GluA1.
The presence of GluA2-containing AMPA receptors is also consistent with the linear current-voltage (I-V) relationship 31 (Fig. 1a) .
TARPs associate with AMPA receptors to control receptor trafficking and function 7 . CaMKII phosphorylation of a specific TARP, stargazin, seems to influence both trafficking of AMPA receptors as well as LTP of hippocampal synapses 32 . We therefore sought to determine whether the effects we observed in hippocampal neurons resulted directly from CaMKII phosphorylation of GluA1-Ser831 or indirectly through phosphorylation of associated proteins such as stargazin. To do this, we measured γ MEAN in hippocampal neurons cultured from phosphodeficient knock-in mice having an alanine at the Ser831 phosphorylation site (GluA1-S831A) or having alanines at both Ser831 and Ser845 (GluA1-S831A,S845A) 12, 16 . Inclusion of CaMKII, Ca 2+ and calmodulin in the patch pipette did not increase the γ MEAN of AMPA receptors from neurons expressing GluA1-S831A,S845A (4.7 ± 0.7 pS; n = 9) compared to control recordings obtained with Ca 2+ and calmodulin alone (5.0 ± 0.8 pS; n = 11; P = 0.75; Fig. 1d ). CaMKII similarly failed to increase γ MEAN in neurons expressing GluA1-S831A (4.4 ± 0.5 pS; n = 15) compared to control (P = 0.54). Introduction of the phosphomimic aspartate in place of GluA1-Ser831 and Ser845 (GluA1-S831D,S845D; Supplementary  Fig. 1 ) significantly increased AMPA receptor γ MEAN (8.4 ± 1.1 pS; n = 12) compared to GluA1-S831A,S845A and GluA1-S831A (P < 0.001, Fig. 1d ). Moreover, the conductance of these phosphomimic mutant native AMPA receptors was not further increased by CaMKII (8.2 ± 1.4 pS; n = 8; P = 0.90; Fig. 1d ). These data show that the increase in unitary conductance, γ MEAN , by CaMKII in native receptors reflects phosphorylation of GluA1-Ser831 and is not an indirect result of phosphorylation of other GluA1 residues or associated regulatory proteins.
Control of recombinant AMPA receptor function by CaMKII
We next explored the mechanistic basis for the CaMKII-dependent increase in γ MEAN . We first tested whether an increase in conductance could fully account for potentiation of the AMPA receptor response Figure 1 CaMKII enhances γ MEAN of hippocampal AMPA receptors recorded in outside-out patches from cultured hippocampal neurons. (a) Photomicrograph of cultured hippocampal neurons (left), I-V relationship (right) (mean ± s.e.m.) and schematic representation of the AMPA receptor subunit GluA1. The segments contributing to subunit domains are indicated below and refer to the amino terminal domain (ATD), the ligand binding domain (LBD-S1 and LBD-S2) and the transmembrane domain (M1 to M4). The amino acid sequence of the C-terminal domain is shown with the four known serine/threonine phosphorylation sites underlined (bottom). (b) Representative macroscopic current response to 1 mM glutamate in excised outside-out patches with 100 µM dl-AP5 and 1 mM Mg 2+ present to block NMDA receptors and cyclothiazide to block AMPA receptor desensitization. The lower trace shows the response after high-pass filtering, illustrating the increase in membrane current noise (dashed box) during channel deactivation. (c) Representative normalized current-variance relationships for two patches comparing the effects of γ MEAN (see Online Methods) for GluA1 responses with and without CaMKII in the pipette. (d) Summary of CaMKII effects on γ MEAN of native AMPA receptors in cultured hippocampal neurons from either wild-type or knock-in mutant mice (mean ± s.e.m.). *P < 0.001 for CaMKII compared to control in wild-type neurons by t-test. # P < 0.001 compared to GluA1-S831A,S845A and GluA1-S831A by two-way ANOVA with Bonferroni's post hoc test. Data are from 8 to 15 neurons for each condition. We recorded the current response to 1 mM glutamate from Xenopus laevis oocytes expressing homomeric GluA1-flip receptors (hereafter, GluA1), without expression of TARPs, using two-electrode voltage-clamp both before and after injection of purified CaMKII (20 ng µl −1 ) directly into the oocytes. CaMKII injection significantly potentiated the current response to 183 ± 15% of control (n = 13, P < 0.001, unpaired t-test) compared to that in buffer-injected oocytes (102 ± 3% of control; n = 5). We subsequently used a rapid perfusion system to apply a maximally effective concentration (10 mM) of glutamate onto excised outside-out patches from human embryonic kidney cell line 293 (HEK) cells transiently transfected with GluA1 ( Supplementary Fig. 2 ). Inclusion of purified CaMKII in the recording pipette increased the γ MEAN determined using nonstationary variance analysis to 175 ± 15% of control (n = 9; P < 0.002, paired t-test), an almost identical increase to that observed from injection of CaMKII directly into oocytes expressing GluA1 ( Table 1) . Identical results were found with stationary variance analysis ( Table 1) . However, CaMKII had no significant effect on γ MEAN when a nonhydrolyzable analog of ATP (4 mM AMP-PNP) was included in the patch pipette (data not shown; P > 0.05, n = 3). Furthermore, CaMKII had no significant effect on γ MEAN of GluA1-S831A, confirming previous findings 5, 17, 18 that the effects of CaMKII on GluA1 reflect actions at Ser831 ( Table 1 ).
In addition, inclusion of CaMKII in the patch pipette did not change the GluA1 response rise time (10-90% rise time, 0.55 ± 0.06 ms) or rate of desensitization (τ = 3.0 ± 0.07 ms; n = 9) compared to control conditions (10-90% rise time, 0.52 ± 0.07 ms; τ = 2.4 ± 0.02 ms; n = 11, P > 0.05, unpaired t-test). GluA1-S831A had the same response time course (10-90% rise time, 0.51 ± 0.07; τ = 2.7 ± 0.03 ms; n = 10) as wild-type receptors. CaMKII also enhanced the γ MEAN of GluA1 receptors that included a mutation converting the protein kinase A (PKA) phosphorylation site Ser845 to alanine (n = 12, data not shown). These results confirm that the primary effects of phosphorylation of GluA1-Ser831 are on single-channel conductance 4 . We also observed a modest increase in open probability determined by nonstationary variance analysis when CaMKII was included in the patch pipette in cells transfected with wild-type GluA1 and a cDNA encoding the PKI inhibitor peptide 8 to reduce basal phosphorylation of Ser845.
Previous studies of the effects of CaMKII on recombinant AMPA receptors in the absence of TARPs showed that CaMKII can increase γ MEAN in homomeric GluA1 but not heteromeric GluA1-GluA2 receptors 33 . We replicated this result in homomeric GluA1 recombinant receptors carrying either a phosphodeficient or phosphomimic mutation at Ser831 (S831A and S831E, respectively). These GluA1 receptors also included a S845A mutation to prevent phosphorylation by endogenous PKA, as well as the L497Y mutation 34 to block macroscopically observed desensitization; we will refer to GluA1-L497Y,S831A,S845A as GluA1-AA and GluA1-L497Y,S831E,S845A as GluA1-EA for simplicity. The γ MEAN determined by variance analysis for GluA1-EA was significantly higher (γ MEAN = 14.2 ± 0.6 pS; n = 19) than that for GluA1-AA (γ MEAN = 9.4 ± 0.7 pS; n = 18; Table 1 ). Similar results were obtained for the double phosphomimic mutant GluA1-L497Y,S831D,S845D (γ MEAN = 13.1 ± 1.0 pS; n = 12; P < 0.001; Table 1 ). The open probability (p O ) of non-desensitizing receptors was unaffected by the phosphomimic mutations ( Table 1) . Consistent with previous findings 33 , the GluA1 phosphomimic mutation did not increase γ MEAN of heteromeric GluA1-GluA2 AMPA receptor responses recorded at −60 mV ( Table 1) ; for all experiments, the edited version of GluA2-L483Y was used. Incorporation of edited GluA2 into the receptor complex lowered the conductance and yielded a linear I-V curve ( Table 1 and Fig. 2a ), confirming that the responses were from heteromeric receptors. However, the γ MEAN values were not significantly different between heteromeric receptors carrying the phosphodeficient GluA1-S831A mutation and the phosphomimic GluA1-S831E mutation (P = 0.65; Table 1 ). These results suggest that the effects of GluA1-Ser831 phosphorylation are determined by the AMPA receptor subunit composition.
HEK cells do not seem to express stargazin 35 . To examine the potential role of stargazin in CaMKII regulation of AMPA receptor function, we repeated experiments with homomeric and heteromeric receptors in cells expressing stargazin. As expected from previous studies, expression of stargazin increased γ MEAN of both homo-and heteromeric receptors ( Table 1) 7, 36 . The presence of stargazin did not modify the effect of the phosphomimic mutation on homomeric GluA1 receptors ( Table 1 ). The γ MEAN of GluA1-EA mutant receptors Some cells were co-transfected with a cDNA encoding the PKI inhibitor peptide 9 . Weighted mean unitary conductance, γ MEAN , was determined using either nonstationary or stationary variance analysis of current responses obtained from transfected HEK cells. Values are mean ± s.e.m.; N is the number of outside-out patches studied at a holding potential of -60 mV. *P < 0.05, significantly different from control (recordings lacking CaMKII); there was no significant difference between GluA1-S831A, GluA1-S831A + CaMKII or wild-type (WT) GluA1 control (ANOVA). **P < 0.01, significantly different from GluA1-L497Y,S831A,S845A, GluA1-L497Y,S831E,S845A or from GluA1-L497Y,S831A,S845A + stargazin (one-way ANOVA with Tukey's post hoc test). Coexpression with stargazin is described in the Online Methods. ***P < 0.05, significantly different from heteromeric receptors containing GluA1-L497Y,S831A,S845A mutant subunits (one-way ANOVA with Tukey's post hoc test). Open probability (p o ) was calculated as the ratio of the maximal macroscopic current to the product of the fitted unitary current and number of channels. One-way ANOVA was used to compare p o values for homomeric GluA1-L497Y mutant and GluA1-GluA2 receptor responses.
a r t I C l e S in cells expressing stargazin (γ MEAN = 16.9 ± 1.0 pS; n = 8; Table 1 ) was significantly higher than that of phosphodeficient GluA1-AA receptors expressed with stargazin (γ MEAN = 12.3 ± 1.1 pS; n = 13; P < 0.01; Table 1 ). Notably, the γ MEAN of GluA1-GluA2 receptors containing the GluA1-EA phosphomimic mutation was significantly higher (γ MEAN = 6.2 ± 0.9 pS; n = 12; Table 1 ) than that of heteromeric receptors with the phosphodeficient GluA1-AA mutation in cells expressing stargazin (γ MEAN = 3.8 ± 0.4 pS; n = 10; P < 0.05; Table 1 ). That is, expression of stargazin with GluA1-GluA2 heteromeric receptors restored the effects of the GluA1-EA mutation on γ MEAN . Open probability was not significantly altered by the phosphomimic mutation in all recordings from non-desensitizing receptors expressed with stargazin ( Table 1 ). The overall conductance of GluA1-GluA2 receptors was lower than homomeric GluA1 receptors and was enhanced by expression of stargazin, confirming the interaction of stargazin and the presence of heteromeric GluA1-GluA2 receptors. One potential confound of our interpretation is the possible presence of a subpopulation of homomeric GluA1-EA receptors in GluA1-GluA2-stargazin-transfected cells, which in theory could account for the observed conductance increase from the GluA1-S831E mutation. To determine whether the different conductance values for phosphomimic and phosphodeficient mutations might reflect a stargazin-enhanced subpopulation of homomeric GluA1 receptors, we repeated this experiment on outward currents recorded at a positive holding potential. At +40 mV, the current contributed by GluA1 homomers should be negligible ( Fig. 2a,b) , allowing us to measure γ MEAN for primarily heteromeric channels. At this holding potential, γ MEAN of heteromeric receptors in the presence of stargazin was still increased by the GluA1-EA mutation (5.9 ± 0.6 pS) compared to that of GluA1-AA (2.9 ± 0.7 pS; P < 0.01). In homomeric GluA1 receptors, stargazin reduced the extent of inward rectification and reduced the rectification ratio of current recorded at +40 mV to -60 mV from 0.26 to 0.43. By contrast, the corresponding rectification ratio for cells expressing heteromeric GluA1-GluA2 (0.66) was not significantly changed upon expression of stargazin ( Fig. 2a,b) . From these values, we calculate that 96% of the current recorded from GluA1-GluA2-stargazin-transfected cells at +40 mV was from heteromeric receptors and 4% from homomeric receptors using the rectification ratios of homomeric GluA1 receptors (Online Methods). We used this relative contribution of GluA1 to the macroscopic current, the weighted γ MEAN values we observed for homomeric receptors, and the weighted γ MEAN for subconductances described in Equation (1) in Online Methods to plot the γ MEAN for mixture of phosphomimic and phosphodeficient GluA1 and GluA1-GluA2 receptors over a range of hypothetical GluA1-GluA2 conductance values ( Fig. 2c) . From this calculation, we can determine the maximal possible difference in the γ MEAN caused solely by conductance contributed from homomeric receptors, underlying 4% of the macroscopic current ( Fig. 2d) . When the change in γ MEAN caused by GluA1-EA is plotted over a range of hypothetical GluA1-GluA2 receptor γ MEAN values, it is clear that the maximum possible conductance increase caused by the GluA1-S831E mutation cannot account for the 213% increase in γ MEAN observed for GluA1-GluA2-stargazin receptors (Fig. 2d) . These results support the finding that CaMKII phosphorylation of GluA1-Ser831 in AMPA receptors that contain the edited GluA2 subunit in complex with stargazin increases conductance.
Although stargazin has been extensively studied, it is not the predominant TARP within the hippocampus. We therefore examined whether phospho-Ser831 increases the conductance of heteromeric AMPA receptors coexpressed with another TARP, γ8, which is highly expressed in the hippocampus, slows deactivation, slows desensitization and prolongs the activation rise time of AMPA receptors [37] [38] [39] . Because the cDNA encoding γ8 is in a vector that also expresses GFP, we were able to confirm expression of γ8 through fluorescent imaging. The conductance of cells expressing GluA1-EA, GluA2 and γ8 was 6.4 ± 1.4 pS (n = 10), compared to 3.0 ± 0.4 pS in cells expressing GluA1-AA, GluA2 and γ8 (n = 11; P < 0.05; Student's t-test; Table 1 ). These data suggest that there is a common property among TARPs that, when in complex with GluA1-containing AMPA receptors, enables a phospho-Ser831-dependent increase in conductance.
Measured increase (213%) 10 60 Figure 2 The increase in γ MEAN from GluA1-GluA2-stargazin-transfected cells is not caused by a stargazin-induced increase in a subpopulation of homomeric GluA1 receptors. (a) Normalized I-V relationship for GluA1 with or without stargazin (STG) and for GluA1-GluA2 with or without stargazin (mean ± s.e.m.). The contribution of GluA1 to rectification was calculated assuming a linear I-V relationship for GluA1-GluA2. (b) Rectification ratios (RR), calculated as the ratio of current amplitude at +40 mV, which reflects primarily GluA1-GluA2 heteromeric receptor current, to that at −60 mV (mean ± s.e.m.; n = 8 to 18 cells for each condition): RR observed = (F A1 )(RR A1-observed ) + (F A1A2 )(RR A1A2-theory ), where F is the fraction of the macroscopic current, RR A1A2-theory was taken to be 0.67 assuming a linear I-V relationship, and F A1 + F A1A2 = 1. From the stargazin-induced change in the rectification ratio, we estimate that co-transfection with GluA1, GluA2 and stargazin leads to 96% GluA1-GluA2 receptors and 4% homomeric GluA1 (Online Methods). (c) Predicted weighted mean conductance, plotted as a function of an unknown GluA1-GluA2 conductance according to equations (4)-(6) (Online Methods). Broken lines show change of the weighted γ MEAN with progressively increasing F A1 using the conductance of GluA1-S831A and GluA1-S831A-GluA2. Solid black line, weighted γ MEAN when F A1 is the 4% homomeric GluA1-S831A receptors with γ MEAN of 9.7 pS determined at +40 mV and 96% GluA1-S831A-GluA2. Solid gray line, weighted γ MEAN for GluA1-S831E with γ of 14.1 pS determined at +40 mV and 96% GluA1-S831E-GluA2. (d) Relationship between the change in weighted γ MEAN induced by the GluA1-S831E alone in a mixed population of GluA1 (4%) and GluA1-GluA2 (96%) receptors over a range of GluA1-GluA2 conductance values, assuming that S831E alters only homomeric GluA1 conductance. Dotted line, the experimentally observed γ MEAN , which is more than that predicted from a conductance increase in only the GluA1 subpopulation.
a r t I C l e S CaMKII increases channel conductance independent of efficacy At the single-channel level, AMPA receptors open to several discrete subconductances 23, [25] [26] [27] . Structural studies of the isolated agonist-binding domain have shown that it can adopt a range of ligand-dependent conformational states, and the extent of domain closure in these agonist-bound crystals is correlated with the probability that a subunit-associated gate will open 24, 26, 40 . Whereas the relationship between the degree of cleft closure observed in these structures and the extent and frequency of domain closure in fulllength receptors expressed in cells remains unclear 26 , the singlechannel conductance seems to be related to subunit-associated gating and agonist efficacy. This led us to hypothesize that Ser831 phosphorylation influences GluA1 subunit gating, which results in an increased relative frequency of larger-conductance openings.
To test this hypothesis, we compared the effect of GluA1-Ser831 phosphorylation on recombinant homomeric GluA1 receptor responses to a range of structurally diverse partial agonists with varied efficacy. To confirm that GluA1-L497Y showed conductance levels similar to those of wild-type GluA1, we evaluated singlechannel currents in outside-out patches in response to a maximally effective concentration of glutamate. The average single-channel subconductances from nine patches containing GluA1-L497Y channels were similar to those previously described for wild-type GluA1 receptors ( Table 2) 8 .
We analyzed the variance of macroscopic current responses from outside-out patches excised from cells transfected with GluA1-L497Y and activated by a variety of ligands ( Fig. 3a,b) . The agonists tested included glutamate and 4-chlorohomoibotenate as representative agonists with high efficacy at GluA1, plus a set of 5-substituted willardiine analogs with low to medium efficacy relative to glutamate 26, 40, 41 Glu CH HW BW IW FW CPW a r t I C l e S ( Fig. 3b) . Variance analysis of the current responses ( Fig. 3c) showed that conductance was correlated with relative agonist efficacy ( Fig. 3d) , as expected if agonists with lower efficacy have a decreased probability of activating an individual subunit 26 . Evaluation of the variance of the macroscopic response showed that inclusion of CaMKII in the pipette solution significantly (P < 0.05 by one-way analysis of variance (ANOVA), n = 4 to 22) increased γ MEAN for all agonists when compared to patches with control solution in the pipette. The rank order of γ MEAN produced by the various agonists was similar for both conditions ( Supplementary Table 1 ).
CaMKII increases channel coupling efficiency
We have previously described the analysis of both variance and singlechannel recordings to quantify the coupling efficiency, ε, between agonist binding and gating for each subunit, which is defined as a value between 0 and 1 (refs. 24, 26, 27) . The value ε describes the probability that an agonist-bound subunit will contribute to ion permeation, assuming all subunits function independently. The relative number of openings to the different conductances can be determined from the binomial probability of four subunits and their coupling efficiency (Online Methods). From these equations we can calculate the relationship between ε and γ MEAN (Fig. 4a; Online Methods) . From the theoretical relationship between γ MEAN and ε for the conductances found for GluA1-L497Y homomeric AMPA receptors, the coupling efficiency of responses to each partial agonist can be extracted (Fig. 4b) .
By performing this analysis for responses with either control or CaMKII in the patch pipette, we were able to show that GluA1-Ser831 phosphorylation produced similar changes in ε regardless of agonist efficacy (Fig. 4c) . These data strongly support our working hypothesis that phosphorylation of GluA1-Ser831 enhances the coupling efficiency between agonist binding and channel gating. A correlation exists between the coupling efficiency and the degree of domain closure of the isolated GluA2 ligand binding domain bound to various agonists 26 . Although a comparable crystallographic data set does not exist for GluA1, we have used the degree of GluA2 domain closure as an estimate of GluA1 domain closure. CaMKII-induced changes in the coupling efficiency occur independently of the degree of domain closure observed in structures of isolated agonist binding domains (Fig. 4d) .
We propose that the lack of correlation (P = 0.09) between domain closure and changes in coupling efficiency (∆ε) suggests that phosphorylation modifies the rate of the conformational changes required for channel activation independent of agonist binding, and of the extent or frequency of ligand-induced domain closure. In other words, GluA1-Ser831 phosphorylation reduces the energy needed for a subunit to undergo transition to an active state that allows ion permeation.
Ser831 controls single-channel coupling efficiency
Previous studies have shown that HEK cells have variable endogenous PKA 8, 42 and protein kinase C (PKC) activity 43 . To eliminate the potentially confounding effects of variable endogenous kinase and phosphatase activity, we used the phosphomutant receptors GluA1-S831A,S845A and GluA1-S831E,S845A to investigate whether CaMKII increases not only the macroscopic but also the single-channel coupling efficiency. Initially, we measured glutamate half-maximum effective concentration (EC 50 ) values for steady state responses in X. laevis oocytes. Wild-type glutamate EC 50 was 16 ± 1 µM for wild-type GluA1, 15 ± 1 µM for GluA1-S831A,S845A and 11 ± 1 µM for GluA1-S831E,S845A (P > 0.2 by one-way ANOVA, n = 9 to 19). We subsequently performed single-channel recordings from cellattached membrane patches obtained from HEK cells expressing these same homomeric GluA1 mutant receptors. Although AMPA receptors have a low single-channel conductance, unitary channel currents were clearly identifiable in the presence of a maximally effective concentration of glutamate (2 mM; Fig. 5a,b) . The profound desensitization of GluA1 receptors reduced the open probability and allowed discrete openings to be observed; individual channel openings occurred infrequently enough to suggest that simultaneous openings were rare. No channel opening events were seen without glutamate added to the pipette or in untransfected cells. We subsequently fitted each opening to a filtered step-response function of variable amplitude using the time course fitting method. One gate open p(� 1 ) = 4�(1 -�) 3 Two gates open p(� 2 ) = 6� 2 (1 -�) 2 Three gates open Figure 4 GluA1-Ser831 phosphorylation increases the coupling efficiency between agonist binding and gating. (a) AMPA receptor subunits (R) contribute to gating once each subunit binds glutamate (G) and becomes activated (*). The theoretical relationship between coupling efficiency (ε) and rate constants (k +1 , k -1 , k +2 , k -2 ) is shown. The efficiency with which each subunit couples to gating (ε) can be calculated from rates of activation as shown. We assume that the distribution of channel conductances (γ) reflects binomial statistics, which allows calculation of the probability of each conductance level, or p(γ). (b) Relationship between coupling efficiency and weighted mean conductance for data from partial agonists activating recombinant GluA1 receptors expressed in HEK cells. Dotted line, relationship between γ MEAN and ε for the conductances found for GluA1-L497Y using a variety of agonists (see Online Methods). Abbreviations as in Figure 3 .
(c) Summary of the effects of CaMKII on coupling efficiency ε for each partial agonist. (d) Relationship between agonist-induced domain closure of the GluA2 ligand binding domain 26, 41 and the change in GluA1 coupling efficiency (∆ε). The ligand binding domain is a clamshell-shaped structure with the ligand binding site located in the cleft formed between two lobes. Ligand binding induces these domains to close around the ligand. Extent of domain closure is dependent on agonist and is quantified by degrees rotation required to fit subdomains upon superimpositions of apo and agonist-bound structures 26, 41 . The degree of domain closure for 4-bromohomoibotenate 40 was used for 4-chlorohomoibotenate. or GluA1-S831E,S845A yielded four subconductances of amplitudes that were similar to those of wild-type GluA1 and GluA1-L497Y (Fig. 5a,b and Table 2 ). However, there was a shift to larger conductance levels in GluA1-S831E,S845A receptors compared to GluA1-S831A,S845A receptors (Fig. 5c,d and Table 3) ; the relative proportion of openings to conductances γ 2 and γ 3 doubled at the expense of γ 1 . If we assume that these four subconductances reflect the opening of an AMPA channel when one, two, three or four of the agonist-bound subunits are activated (Fig. 5a) , then the binomial theorem should predict the relative frequency of each sublevel for all possible values of subunit coupling efficiencies 26 . From the known values of the relative frequency and amplitude of openings to different conductances, we can determine ε from the γ MEAN that we measured using variance analysis. Single-channel data ( Table 2) show that ε is greater in homomeric GluA1 receptors with the mutation S831E than in those with the mutation S831A (Fig. 5e) . In addition, the binomial representation of independent subunit gating can account for the single-channel properties in both GluA1-S831E,S845A and GluA1-S831A,S845A receptors (Fig. 5f) . These data support the working hypothesis that phosphorylation of GluA1-Ser831 enhances subunit gating, which explains our findings, as well as previous studies 4 , showing that phospho-Ser831 increases the frequency of larger conductance levels as individual subunits become more easily activated.
DISCUSSION
We have used macroscopic and singlechannel recording to explore the functional and structural mechanisms that underlie CaMKII-dependent regulation of GluA1containing AMPA receptors. In addition, we have shown that CaMKII increases conductance of native hippocampal AMPA receptors specifically by means of actions at GluA1-Ser831, by evaluation of AMPA receptor response properties in the GluA1 phosphomutant knock-in mice. Moreover, previous studies in recombinant systems in a b Figure 5 GluA1-S831E phosphomimic mutation increases the frequency of higher conductance openings and increases the singlechannel coupling efficiency. (a,b) Individual single-channel current traces recorded from recombinant phosphomutant GluA1-S831A,S845A and GluA1-S831E,S845A in cell-attached membrane patches in HEK cells with 2 mM glutamate in the patch pipette. These receptors were desensitizing and did not contain the L497Y mutation. (c,d) Representative amplitude histogram from individual patches constructed from the fitted amplitudes of individual openings using time course fitting. Histograms were fitted with the sum of four Gaussian components (± s.d.). (e) Prediction by the binomial theory of the relative proportion of subconductances for GluA1-S831A and GluA1-S831E mutations given the calculated values for coupling efficiency for GluA1 in cyclothiazide in Table 3 . (f) Relationship between coupling efficiency and mean conductance, constructed similarly to Figure 4b using values for γ MEAN listed in Table 3 for GluA1 in cyclothiazide; error bars, s.e.m. The dotted line was fit as in Figure 4b . Homomeric GluA1 macroscopic current responses in outside-out patches from HEK cells were induced by 1 mM glutamate followed by a slow washout. Variance analysis of the response was used to estimate weighted mean conductance (γ MEAN ). Values are mean ± s.e.m. a r t I C l e S the absence of TARPs established that CaMKII phosphorylation of GluA1-Ser831 increases the single-channel conductance of homomeric GluA1 receptors, but not of heteromeric GluA1-GluA2 receptors 4, 33 . We have confirmed this result, but further show that the GluA1-S831E phosphomimic mutation increases conductance of heteromeric GluA1-GluA2 recombinant channels when either stargazin or γ8 are present. These observations suggest that the results and mechanisms described here are relevant to the abundant heteromeric GluA1-GluA2 receptors in neurons. Two hypotheses exist to describe the mechanism underlying the change in conductance brought about by phospho-Ser831. Either phosphorylation of GluA1-Ser831 increases ion flux through the pore for all conductance levels, or it alters gating to allow larger conductances to open more often. Our data support the second hypothesis, as conductance amplitudes of recombinant homomeric GluA1 receptors were unchanged by mimicking phosphorylation of Ser831. In a similar way, the TARP stargazin increases the frequency of larger GluA4 conductance openings 7 . Moreover, our data show that phosphorylation of GluA1-Ser831 increases γ MEAN for agonists of varying efficacy and subunit coupling efficiency independent of the degree of domain closure induced by these agonists, determined in crystal structures of the isolated ligand-binding domain. This suggests that phosphorylation can facilitate the subunit-specific conformational changes that occur after agonist binding. This allows the pore to open to four quantized conductances related to the fraction of the four subunits that are activated at the moment the pore rapidly dilates. That is, our data are compatible with a model in which a conformational change that is independent of pore opening takes place in each of four agonistbound subunits, and the conductance of the pore when open is set by the number of subunits that have undergone this conformational change. The position of the pre-M1 helix in the GluA2 structure 3 provides a potential site at which agonist-induced rearrangement could influence pore conductance.
Our coupling efficiency calculations are based on the binomial expansion, in which we make the assumption that the four subunits that comprise the AMPA receptor operate independently of one another. In light of the tetrameric GluA2 crystal structure, which shows that the extracellular domains are likely arranged as a dimer-of-dimers 3 , it is possible that all four subunits do not function independently. However, use of the binomial expansion to estimate coupling efficiency successfully describes single-channel opening frequency for a variety of partial agonists at AMPA receptors 24, 26, 27 . Moreover, recent data suggest that detectable subunit cooperativity occurs at low but not high agonist concentrations 27 . Thus, if adjacent subunits influence the function of one another, it seems likely that the effects on coupling efficiency are minimal for the saturating concentrations of agonist used in this study.
Phosphorylation critically regulates many facets of glutamate receptor function. PKA phosphorylates GluA1 to increase the peak response open probability, perhaps as a consequence of altering a slow equilibrium between functional and nonfunctional states, which may reflect binding and dissociation of intracellular proteins 8 . In addition, phosphorylation of GluA1 by PKC is critical for LTP expression and incorporation of GluA1 subunits into the synapse 44, 45 . Moreover, the anchoring proteins SAP97 and AKAP97 reduce the concentration of PKC necessary to phosphorylate GluA1-Ser831 by positioning it close to its substrate 46 . Regulation of GluA1 function and trafficking underlies many forms of activity-dependent synaptic plasticity 2, 6, 9, 10, 12, 13, 16, 19, 43, 47 , and CaMKIIdependent phosphorylation of GluA1-Ser831 has been hypothesized to influence LTP and synaptic strength 10, 16 . Thus, understanding the functional and structural mechanisms of GluA1-Ser831 phosphorylationinduced changes in AMPA receptor function is crucial for understanding the molecular changes that occur during activity-dependent synaptic plasticity, a leading model of learning and memory. Although this study establishes that GluA1-Ser831 phosphorylation enhances coupling efficiency independent of agonist efficacy, further studies are needed to establish the structural basis by which GluA1 phosphorylation changes AMPA receptor gating. One possible explanation is that intra-or interprotein interactions may induce functional changes in the channel. Also, there are at least four GluA1 phosphorylation sites that are implicated in synaptic plasticity (Fig. 1a) , including Ser818 (PKC) 44, 45 , Ser831 (CaMKII, PKC) 4, 5, 17 , Thr840 (PKC, p70S6 kinase) 48, 49 and Ser845 (PKA, cyclic GMP-dependent protein kinase II) 8, 50 . The presence of four phosphorylation sites in only 27 residues of the GluA1 C-terminal domain raises structural, biophysical and biological questions as to the function of this highly regulated region of the GluA1 protein. Functional interactions between these phosphorylation sites or between this region of GluA1 and potential intracellular interaction partners have yet to be experimentally addressed. Future work evaluating these ideas may provide a structural framework around which to further explore the mechanism by which GluA1 phosphorylation influences AMPA receptor function.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
ONLINE METHODS
materials.
Purified CaMKII (5 × 10 6 U mg −1 ; unit activity as defined by the manufacturer) and calmodulin were obtained from New England Biolabs and activated according to the manufacturer's protocol. NBQX (2,3-dihydroxy-6nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione, a nonselective AMPA receptor antagonist) and the AMPA receptor partial agonists (S)-(-)-5-fluorowillardiine, (S)-(-)-5-iodowillardiine, (S)-(-)-5-bromowillardiine, (S)-willardiine, (S)-1H-cyclopentapyrimidine-2,4(1H,3H)-dionewillardiine (CPW399) and 4-chlorohomoibotenic acid, as well as dl-AP5 (NMDA receptor antagonist) and cyclothiazide (AMPA receptor desensitization blocker), were obtained from Tocris. NS1209 was a gift from NeuroSearch A/S. Spermine was obtained from Sigma-Aldrich (S2876). Poly-d-lysine was obtained from Millipore (A-003-E). All cell biology reagents were from Gibco (Invitrogen) unless otherwise stated. molecular biology. The cytomegalovirus promoter-containing mammalian expression vector pRK5 (BD Pharmingen) harboring the coding sequences of the flip splice variants of the rat GRIA1 and GRIA2 genes was used for transient expression of GluA1 and edited GluA2 in mammalian cells. The mutations GluA1-L497Y and GluA2-L483Y, as well as GluA1-Ser831 and GluA1-Ser845 mutations to alanine, glutamate or aspartate were introduced by QuikChange mutagenesis (Stratagene). All mutations were verified by DNA sequencing (SeqWright, Fisher Scientific). The stargazin construct was contained in a pCIneo vector; the γ8 construct was in an IRES-eGFP vector. GluA1 and GluA2 cDNA was provided by P. Seeburg and γ8 cDNA by R. Nicoll. maintenance and transfection of Hek cells. HEK293 cells (ATCC 1573) were grown in DMEM (Gibco 10569) supplemented with 10% (vol/vol) FCS (Gibco, 26400) and 1% (vol/vol) penicillin-streptomycin solution (Gibco, 15140-122) in polystyrene culture dishes in a humidified atmosphere of 5% CO 2 , 95% O 2 , at 37 °C. Growth media for transiently transfected GluA1 cells were supplemented with 100 µg ml −1 NS1209 or 200 µM NBQX to protect transfected cells against excitotoxicity induced by endogenous glutamate in the growth media. Cells were dissociated using 0.05% (wt/vol) trypsin-EDTA (Gibco, 25300), plated on 8-mm glass coverslips coated with 20 µg ml −1 poly-d-lysine contained in 24-well plates and transfected 24 h before experimentation using FuGene6 (Invitrogen). Briefly, plasmid DNA was diluted in DMEM to 10 µg ml −1 , supplemented with 30 µl ml −1 FuGene6, incubated for 15 min at 37 °C and added to cells using 20 µl mix per cm 2 growth area. Plasmid DNA harboring a reporter cDNA encoding GFP (pMAXGFP, Amaxa) was added to receptor DNA at a 1:4 ratio to identify transfected cells.
Preparation of hippocampal neuron cultures.
All procedures involving the use of animals were reviewed and approved by the Emory University institutional animal care and use committee. The hippocampal formation was dissected from postnatal day 0 wild-type C57Bl/6, GluA1-S831A, GluA1-S831A,S845A or GluA1-S831D,S845D knock-in mice 16 . Tissue was incubated in medium comprising (in mM) 82 Na 2 SO 4 , 30 K 2 SO 4 , 5.8 MgCl 2 , 0.25 CaCl 2 , 1 HEPES buffer, 3.6% (wt/vol) glucose, 0.1 kynurenic acid, phenol red, with pH adjusted to 7.4 with NaOH. Hippocampal tissue was digested in 20 µg ml −1 papain (LS003124, Worthington) for 15 min, then transferred to a 30 mg ml −1 ovomucoid trypsin inhibitor solution (Sigma-Aldrich, T92531) for 15 min. The tissue was triturated in OPTI-MEM solution (Gibco, 31985) supplemented with 2.5% (wt/vol) glucose using two Pasteur pipettes of different bore sizes. Cells were diluted to a concentration of 2 × 10 5 cells per milliliter in OPTI-MEM and 1 ml was plated onto 50 µg ml −1 poly-d-lysine-coated glass coverslips (diameter 8 mm) in 24-well plates. After the cells were allowed to settle for 1 h, OPTI-MEM was exchanged for Neurobasal medium (Gibco, 21103), supplemented 1:500 (vol/vol) with 100× Glutamax (Gibco, 35050), 1:50 (vol/vol) with 50× B-27 and 1:100 (vol/vol) with 10,000 U ml −1 penicillin plus 10 mg ml −1 streptomycin. Cells were cultured for 7-25 d in 95% O 2 , 5% CO 2 at 37 °C, and medium was exchanged every 7 d.
Two electrode voltage clamp recording from Xenopus oocytes. Female X. laevis were anesthetized using 0.3% (wt/vol) ethyl 3-aminobenzoate (Sigma-Aldrich, A5040), and the ovaries were surgically removed. Stage V and VI oocytes were isolated after a 2-h incubation of the ovaries in 2 mg ml −1 collagenase at 20-25 °C. Oocytes were injected the next day with 50 ng of cRNA encoding wild-type or mutant GluA1 that was transcribed in vitro (mMessage mMachine, Ambion). Injected oocytes were maintained at 17 °C in Barth's solution, comprising (in mM) 88 NaCl, 1 KCl, 2.4 NaHCO 3 , 0.82 MgSO 4 , 0.33 Ca(NO 3 ) 2 , 0.41 CaCl 2 , and 20 mM HEPES-Tris, with pH adjusted to 7.5, and containing gentamicin sulfate (0.1 mg ml −1 ) for 3-6 d, after which recordings were made at 23 °C from cells perfused in a solution containing (in mM) 115 NaCl, 5 HEPES, 2 KCl, 1.8 CaCl 2 , pH 7.0. Recording pipettes were filled with 3 M KCl. For measurements of potentiation of current responses by injection of CaMKII during recording, glutamate (1 mM) was used to activate steady-state current responses recorded during two-electrode voltage clamp before and 20 min after microinjection of 5-20 nl of purified CaMKII (20 ng µl −1 ). The degree of potentiation was calculated as the ratio of the amplitude of the test response to the control response.
Voltage clamp recordings from outside-out patches. Outside-out membrane patches were excised from transiently transfected HEK cells or cultured hippocampal neurons at 23 For measurement of rapidly desensitizing current responses, a piezobimorphdriven double-barreled perfusion system was used to rapidly apply saturating concentrations of agonist onto excised membrane patches for 100-200 ms, as previously described 42 . The time course of solution exchange across the laminar flow interface was estimated by liquid junction potential to be 0.2-0.4 ms (10-90% rise time); the time course of the junction potential change for our perfusion system was measured at the end of most experiments. We used maximally effective concentrations of agonists (glutamate, 1 mM; willardiine, 200 µM; 5-iodowillardiine, 100 µM; CPW399, 200 µM; 5-bromowillardiine, 100 µM; 4-chlorohomoibotenic acid, 500 µM) based on previously determined EC 50 values. For cultured neurons, NMDA receptor responses were blocked by the addition of 100 µM dl-AP5 and 1 mM Mg 2+ . Nonstationary and stationary variance analysis of macroscopic currents was carried out as previously described 8, 26, 29 . The weighted mean conductance is related to j subconductances by the equation
where N is the number of channels, γ j is conductance of the j th sublevel and p j is the open probability for each of the conductances. For determination of the coupling efficiency ε, p j was determined from binomial expansion for values of ε between 0 and 1. A theoretical curve relating coupling efficiency to weighted γ MEAN was generated from equation (1) using measured conductances and the binomial equation (Fig. 4) . From this curve, we estimated the relative sublevel occupancy for values of ε between 0 and 1 needed to obtain the expected weighted conductance. Coupling efficiency ε can then be determined by comparing this theoretical relationship to the experimental values for the weighted γ MEAN from variance or single-channel analysis of the GluA1 responses under various experimental conditions. The response amplitude to a maximally effective concentration of agonist can similarly be predicted from the probability of openings to each conductance level by Response amplitude = ∑ V Np j j g Response amplitude = ∑ V Np j j g where V is the membrane holding potential and N, γ and p are as defined above.
Values of ε for different agonists can also be determined by comparison of the experimentally determined partial agonist/glutamate response amplitude ratio and the predicted relationship between ε and response ratio. Identical values of ε were determined using conductance or response amplitude (data not shown).
(1) (1)
(2) (2) Rectification ratios in Figure 2 were obtained from the equation where F A1 is the fraction of the macroscopic current carried by homomeric GluA1, F A1A2 is the fraction of macroscopic current carried by heteromeric GluA1-GluA2, and F A1 + F A1A2 = 1. For GluA1-stargazin-transfected cells, RR A1-observed was 0.43, and for GluA1-GluA2-stargazin-transfected cells, RR observed was 0.66; a linear I-V yields RR A1A2-theory of 0.67. The predicted weighted γ MEAN presented in Figure 2 was obtained by inserting expressions for macroscopic current, where N is the number of channels and P is the open probability, Single-channel recordings from cell-attached patches. Recordings of singlechannel currents from HEK cells expressing recombinant GluA1 were made at 23 °C using the cell-attached patch-clamp configuration with Sylgard (Dow Corning)-coated thick-walled micropipettes (1.5 mm outer diameter, 0.86 mm inner diameter) with resistances of 7-12 MΩ. The recording pipettes were filled with extracellular solution; holding potential was −80 to −100 mV (patch pipette, +80 to +100 mV). The resting membrane potential of each cell was measured under current clamp at the end of each experiment by disruption of the membrane. Single-channel activity was evoked by a maximally effective concentration
(4) (4)
of glutamate (2 mM) in the recording pipette. Records were digitized at 20 kHz and filtered on-line using a Gaussian filter (5 kHz; -3 dB). Single-channel currents activated by glutamate are brief and of low amplitude and thus difficult to distinguish from momentary noise. To obtain an estimate of the relative amplitudes of subconductance states, the following measures were taken to verify that analyzed signals were from glutamate-activated GluA1 channels. First, in three experiments in which 30 s of cell-attached current recordings were analyzed for single-channel openings in the absence of glutamate, the frequency of apparent transitions was on average 4.8% of the frequency of apparent transitions in the presence of 2 mM glutamate (P < 0.001). In addition, the mean unitary current amplitude in the absence of glutamate was 0.05 pA, lower than that of events detected in the presence of glutamate. This result strongly suggests that the unitary currents that we measured indeed arise from glutamate gating of homomeric GluA1 rather than patch breakdown or other sources of noise. Second, only patches with an r.m.s. value < 0.2 pA (after off-line filtering at 1 kHz, -3 dB) for control records were included in analysis (mean r.m.s. 0.12 ± 0.04 pA; n = 10 patches). Single-channel openings were analyzed using the time course fitting method implemented in SCAN (provided by D. Colquhoun); transitions briefer than 2.0 filter-rise times (that is, 98% of full amplitude) were excluded from the analysis of amplitude histograms. All apparent transitions greater in amplitude than 2 r.m.s. between the open and closed states were fitted, and the resulting idealized records were revised by imposing a minimum resolvable duration for open and shut periods (120 µs); refitting the data imposing a 200-µs resolution produced similar results. The data comprising the amplitude histograms were fitted to the sum of four Gaussian components by the maximum likelihood method using EKDIST (D. Colquhoun).
Statistical methods. Unless otherwise noted, results are expressed as mean ± s.e.m. Statistical analysis of pairwise or multiple comparisons were performed using ANOVA or Student's t-test as appropriate. P < 0.05 was considered to be statistically significant.
